KP
Karuppannan Poongodi Murali
About Karuppannan Poongodi Murali
Data last updated:
Karuppannan Poongodi Murali is a Whole-Time Director at Somerset Therapeutics Private Limited (since 2021). The companies operate in Chemicals and Research & Development. Somerset Therapeutics Private Limited reported revenue of ₹298 Cr (FY 2025). Earlier, Karuppannan Poongodi Murali was a Director at Novel Clinical Research (India) Private Limited (2015–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Somerset Therapeutics Private Limited U85110KA1990PTC011166 | Whole-Time Director | 01 Jan 2021 | 1990 | ₹298 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novel Clinical Research (India) Private Limited U73100KA2012FTC067065 | Director | 02 Jan 2015 | 2012 | ₹3.3 Lakh (FY 2017) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Karuppannan Poongodi Murali
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jinal Jain M | Somerset Therapeutics Private Limited | Company Secretary | |
| Kannilakshmaniyer Krishnamachary Paranjyothi | 02004861 | Somerset Therapeutics Private Limited | Director |
| Mohanambal Paramasivam Gounder | 10543780 | Somerset Therapeutics Private Limited | Director |
| Ramasamy Anbarasi Thirumoorti | 02157286 | Somerset Therapeutics Private Limited | Director |
| Sudhakar Varamballi Krupendra | Somerset Therapeutics Private Limited | Cfo | |
| Velusamy Jaiashokan | 10500765 | Somerset Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Karuppannan Poongodi Murali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karuppannan Poongodi Murali
Karuppannan Poongodi Murali currently holds 1 directorship: Somerset Therapeutics Private Limited (Whole-Time Director, since 01 Jan 2021, revenue ₹298 Cr (FY 2025)).
Karuppannan Poongodi Murali was first appointed on 02 Jan 2015 as Director at Novel Clinical Research (India) Private Limited. The most recent appointment on record is 01 Jan 2021 at Somerset Therapeutics Private Limited.
Karuppannan Poongodi Murali held 1 earlier board appointment: Novel Clinical Research (India) Private Limited (Director, 02 Jan 2015 to 01 Dec 2016).
The current boards of Karuppannan Poongodi Murali's companies include Jinal Jain M (Somerset Therapeutics Private Limited), Kannilakshmaniyer Krishnamachary Paranjyothi (Somerset Therapeutics Private Limited), Mohanambal Paramasivam Gounder (Somerset Therapeutics Private Limited), Ramasamy Anbarasi Thirumoorti (Somerset Therapeutics Private Limited), Sudhakar Varamballi Krupendra (Somerset Therapeutics Private Limited), Velusamy Jaiashokan (Somerset Therapeutics Private Limited).